Morphic Holding, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 48 rows in 2021. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-12-29: Reporting owner DeVaul William; Form 4; Security Stock Option (right to buy Common Stock); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2021-11-03: Reporting owner Farrell Robert E Jr; Form 4; Security Stock Option (right to buy Common Stock); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2021-11-02: Reporting owner SCHEGERIN MARC; Form 4; Security Stock Option (right to buy Common Stock); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2021-11-01: Reporting owner SCHEGERIN MARC; Form 4; Security Stock Option (right to buy Common Stock); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-12-29 | DeVaul William Officer (General Counsel and Secretary) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,452 15,508 owned after | $15.00 exercise price | 2021-12-30 | |
| 2021-11-03 | Farrell Robert E Jr Officer (SVP Finance and CAO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 60,270 owned after | $4.32 exercise price | 2021-11-03 | |
| 2021-11-02 | SCHEGERIN MARC Officer (CFO and COO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,666 183,934 owned after | $15.00 exercise price | 2021-11-03 | |
| 2021-11-01 | SCHEGERIN MARC Officer (CFO and COO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,477 190,600 owned after | $15.00 exercise price | 2021-11-03 | |
| 2021-10-26 | SCHEGERIN MARC Officer (CFO and COO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −37 196,077 owned after | $15.00 exercise price | 2021-10-28 | |
| 2021-10-19 | Rogers Bruce Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,000 167,713 owned after | $4.32 exercise price | 2021-10-21 | |
| 2021-10-15 | SCHEGERIN MARC Officer (CFO and COO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,338 196,114 owned after | $15.00 exercise price | 2021-10-15 | |
| 2021-10-14 | SCHEGERIN MARC Officer (CFO and COO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,184 199,452 owned after | $15.00 exercise price | 2021-10-15 | |
| 2021-10-13 | SCHEGERIN MARC Officer (CFO and COO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,964 223,636 owned after | $15.00 exercise price | 2021-10-15 | |
| 2021-09-13 | Rogers Bruce Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,721 180,713 owned after | $4.32 exercise price | 2021-09-13 | |
| 2021-09-10 | Farrell Robert E Jr Officer (SVP Finance and CAO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,974 70,270 owned after | $4.32 exercise price | 2021-09-14 | |
| 2021-09-10 | Rogers Bruce Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,279 182,434 owned after | $4.32 exercise price | 2021-09-13 | |
| 2021-09-09 | Rogers Bruce Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 190,713 owned after | $4.32 exercise price | 2021-09-13 | |
| 2021-08-19 | Nanda Nisha Director | 4/A | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,177 18,177 owned after | $56.30 exercise price | 2022-04-29 | |
| 2021-08-19 | Nanda Nisha Director | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $56.30 exercise price | 2021-08-23 | |
| 2021-06-18 | Farrell Robert E Jr Officer (SVP Finance and CAO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −200 75,244 owned after | $4.32 exercise price | 2021-06-21 | |
| 2021-06-16 | SPRINGER TIMOTHY A Director, 10% Owner | 4/A | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,996 9,996 owned after | $64.79 exercise price | 2022-04-29 | |
| 2021-06-16 | SLATTERY JOSEPH P Director | 4/A | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,615 9,615 owned after | $64.79 exercise price | 2022-04-29 | |
| 2021-06-16 | Nashat Amir Director | 4/A | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,910 9,910 owned after | $64.79 exercise price | 2022-04-29 | |
| 2021-06-16 | GRAY SUSANNAH Director | 4/A | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +0 0 owned after | $64.79 exercise price | 2022-04-29 | |
| 2021-06-16 | Edwards Martin Director | 4/A | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,996 9,996 owned after | $64.79 exercise price | 2022-04-29 | |
| 2021-06-16 | Christensen Gustav Director | 4/A | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,150 9,150 owned after | $64.79 exercise price | 2022-04-29 | |
| 2021-06-16 | BISCHOFBERGER NORBERT W Director | 4/A | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,888 9,888 owned after | $64.79 exercise price | 2022-04-29 | |
| 2021-06-16 | Farrell Robert E Jr Officer (SVP Finance and CAO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −300 75,444 owned after | $4.32 exercise price | 2021-06-21 | |
| 2021-06-16 | SPRINGER TIMOTHY A Director, 10% Owner | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $64.79 exercise price | 2021-06-17 | |
| 2021-06-16 | SLATTERY JOSEPH P Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $64.79 exercise price | 2021-06-17 | |
| 2021-06-16 | Nashat Amir Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $64.79 exercise price | 2021-06-17 | |
| 2021-06-16 | GRAY SUSANNAH Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $64.79 exercise price | 2021-06-17 | |
| 2021-06-16 | Edwards Martin Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $64.79 exercise price | 2021-06-17 | |
| 2021-06-16 | Christensen Gustav Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $64.79 exercise price | 2021-06-17 | |
| 2021-06-16 | BISCHOFBERGER NORBERT W Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $64.79 exercise price | 2021-06-17 | |
| 2021-06-14 | Farrell Robert E Jr Officer (SVP Finance and CAO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,526 75,744 owned after | $4.32 exercise price | 2021-06-14 | |
| 2021-06-10 | Farrell Robert E Jr Officer (SVP Finance and CAO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,000 79,270 owned after | $4.32 exercise price | 2021-06-14 | |
| 2021-04-27 | GRAY SUSANNAH Director | 4/A | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,111 18,111 owned after | $55.46 exercise price | 2022-04-29 | |
| 2021-04-27 | GRAY SUSANNAH Director | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $55.46 exercise price | 2021-04-29 | |
| 2021-03-16 | DeVaul William Officer (General Counsel and Secretary) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,027 113,854 owned after | $4.32 exercise price | 2021-03-17 | |
| 2021-03-15 | DeVaul William Officer (General Counsel and Secretary) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −45,973 127,881 owned after | $4.32 exercise price | 2021-03-17 | |
| 2021-02-03 | Farrell Robert E Jr Officer (SVP Finance and CAO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 95,270 owned after | $4.32 exercise price | 2021-02-03 | |
| 2021-02-02 | Tipirneni Praveen P. Director, Officer (President and CEO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,932 401,785 owned after | $4.32 exercise price | 2021-02-03 | |
| 2021-02-01 | Tipirneni Praveen P. Director, Officer (President and CEO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 413,717 owned after | $4.32 exercise price | 2021-02-03 | |
| 2021-01-15 | Tipirneni Praveen P. Director, Officer (President and CEO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +205,000 205,000 owned after | $30.19 exercise price | 2021-01-19 | |
| 2021-01-15 | SCHEGERIN MARC Officer (CFO and COO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +83,000 83,000 owned after | $30.19 exercise price | 2021-01-19 | |
| 2021-01-15 | Rogers Bruce Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +83,000 83,000 owned after | $30.19 exercise price | 2021-01-19 | |
| 2021-01-15 | Officer (Chief Medical Officer) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +83,000 83,000 owned after | $30.19 exercise price | 2021-01-19 | |
| 2021-01-15 | Farrell Robert E Jr Officer (SVP Finance and CAO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $30.19 exercise price | 2021-01-19 | |
| 2021-01-15 | Officer (General Counsel and Secretary) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $30.19 exercise price | 2021-01-19 | |
| 2021-01-05 | Tipirneni Praveen P. Director, Officer (President and CEO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,653 417,717 owned after | $4.32 exercise price | 2021-01-06 | |
| 2021-01-04 | Tipirneni Praveen P. Director, Officer (President and CEO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,347 419,370 owned after | $4.32 exercise price | 2021-01-06 |